
Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) announced that it recently filed a new provisional patent application with the United States Patent and Trademark Office (‘USPTO’) entitled “NSAID Formulation …
Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method Read More